AYTU BIOPHARMA, INC Notes Payable, Related Parties, Current
AYTU BIOPHARMA, INC (AYTU) had Notes Payable, Related Parties, Current of $8.00 million as of 2015-03-31, per its 10-Q filed 2015-05-19.
Discontinued › Notes
us-gaap:NotesPayableRelatedPartiesClassifiedCurrent · last filed 2015-09-28
- 2015-03-31: Notes Payable, Related Parties, Current $8.00M.
- 2014-06-30: Notes Payable, Related Parties, Current $4.60M; Notes Payable, Related Parties, Current as first filed $4.30M.
| Period end | Notes Payable, Related Parties, Current | Notes Payable, Related Parties, Current as first filed |
|---|---|---|
| 2015-03-31 | $8.00M 10-Q · filed 2015-05-19 | |
| 2014-06-30 | $4.60M 10-K · filed 2015-09-28 | $4.30M 10-Q · filed 2015-05-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |